Hyundai Pharm

Seoul, South Korea Founded: 1965 • Age: 61 yrs Listed
Pharmaceuticals and consumer health products are manufactured and marketed.

About Hyundai Pharm

Hyundai Pharm is a publicly listed company based in Seoul (South Korea) founded in 1965. Pharmaceuticals and consumer health products are manufactured and marketed. The company has 401 employees. Its website hyundaipharm.co.kr draws about 26 thousand monthly visits. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.

Company details

Founded in 1965 and headquartered in Seoul, South Korea, operations are centered on the pharmaceuticals and consumer health sector. A diverse portfolio of products is developed and marketed, covering therapeutic areas such as over-the-counter medications, energy drinks, and hair care solutions. Innovation is pursued through new product launches and line expansions. Corporate social responsibility is addressed via initiatives like sponsorship of cultural events.

  • Headquarters Seoul, South Korea
  • Employees 401
  • Stage Public
  • Sectors
    Healthcare
  • Website hyundaipharm.co.kr
  • Social LinkedIn X
  • Legal Name Hyundai Pharmaceutical Co., Ltd.
Key Metrics
  • Annual Revenue
    $130.5 M (USD)
    9.14
    as on Nov 30, 2025
  • Net Profit
    $1.71 M (USD)
    as on Nov 30, 2025
  • EBITDA
    $5.16 M (USD)
    95.89
    as on Nov 30, 2025
  • Employee Count
    401

IPO & Listings of Hyundai Pharm

Hyundai Pharm is a publicly listed company on the KRX with ticker symbol 004310 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date28 Jun 1978
  • Listed onKRX: 004310
  • Listed entityHyundai Pharmaceutical Co., Ltd.
  • Exchange sectorHealth technology
  • ISINKR7004310009
  • Share price7,580.00 KRW (-0.66% on the day) · 2026-10-14
  • Market capitalisation235,891,760,559.00 KRW
  • Price to earnings46.6
  • EPS (diluted, trailing year)162.83 KRW
  • Dividend yield0.39%
  • Volume (last session)407,544

Financials of Hyundai Pharm

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025191.79B KRW2.52B KRW7.58B KRW
2024175.74B KRW-574.9M KRW3.87B KRW
2023180.76B KRW6.12B KRW10.23B KRW
2022162.69B KRW-164.6M KRW11.27B KRW
2021139.80B KRW-3.17B KRW2.41B KRW
Premium access

Detailed financial statements for Hyundai Pharm

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Hyundai Pharm

The website of Hyundai Pharm (hyundaipharm.co.kr) receives about 25.8K visits a month.

  • Monthly visits
    25.8K

    ▼ 0.5% vs previous month

Similar websites

Websites whose visitors overlap most with Hyundai Pharm. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
dongsung-pharm.com
100%
22.7K#1,423,529View details
choa.co.kr
79%
14K#1,738,079View details
health.kr
56%
#14,868View details
mmpharm.co.kr
48%
25.5K#769,589View details
daedamo.com
48%
680.7K#100,922View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 11 similar websites and full traffic analytics for Hyundai Pharm

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 11 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Hyundai Pharm

Premium access

Complete news archive for Hyundai Pharm

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hyundai Pharm

Hyundai Pharm was founded in 1965.

Hyundai Pharm is headquartered in Seoul, South Korea.

Hyundai Pharm has 401 employees.

Annual revenue of Hyundai Pharm is $130.5M as on Nov 30, 2025.

Founded in 1965 and headquartered in Seoul, South Korea, operations are centered on the pharmaceuticals and consumer health sector. A diverse portfolio of products is developed and marketed, covering therapeutic areas such as over-the-counter medications, energy drinks, and hair care solutions. Innovation is pursued through new product launches and line expansions. Corporate social responsibility is addressed via initiatives like sponsorship of cultural events.

Yes, Hyundai Pharm is publicly traded on KRX under the ticker symbol 004310.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available